What are the common themes in acute leukemia adult stories?A common theme is the struggle with the side effects of treatment. Adults with acute leukemia often have to endure a lot, such as nausea, weakness, and susceptibility to infections. Also, the financial burden is a theme in some stories. The cost of treatment can be very high, and some patients may have to find ways to cover the expenses while dealing with the illness.
Can you share some acute leukemia adult stories?Sure. One story is about a 35 - year - old man. He was diagnosed with acute leukemia suddenly. At first, he was in shock and denial. But then, with the support of his family and the medical team, he started chemotherapy. He faced many side effects like hair loss and extreme fatigue, but he never gave up. He became an inspiration for other patients in the hospital.
What are some acute myeloid leukemia success stories?One success story is about a patient who was diagnosed with acute myeloid leukemia at a young age. Through a combination of intense chemotherapy and a bone marrow transplant from a matching donor, the patient fully recovered. After the treatment, regular check - ups showed no signs of the disease returning, and the patient was able to return to a normal life, going back to school and participating in sports.
2 answers
2024-10-28 10:37
What drugs are there to suppress acute marrow leukemia?The drugs used to treat acute marrow leukemia included chemotherapy drugs and targeted drugs.
1. The main drugs for chemotherapy were mitoxantrone, daunorubin, cytarine, aclacinoxin, homoharringtonine, and so on. The most common adverse reactions were digestive tract reactions (such as nausea, vomiting, etc.) and bone marrow suppression (such as leukemia, chemotherapy, etc.).
2. Target drugs: It mainly included gireitini (FLVT3), vineclakra, midostemine (FLVT3), evonib (IDH1), gemtubiza (CD33), ensidipine (IDH), gilitini, sorafenib, etc. Common side effects included skin itching, rash, and digestive tract reactions; There are also Iso-Citrate Dehydrase 1 or 2 (IDH1/2) Inhibition Agents, such as Ivosidenb (IDH1 Inhibition Agent) and Enasidenb (IDH2 Inhibition Agent), which are effective in the treatment of IDH1 and IDH2 Mutated AML. FLVT3 Tyrosin Kinase Inhibition, such as Midostaurin, Quizartniang, etc.; Newer specific FLVT3 Inhibition, such as Lesturtniang, Gliteritniang, and Crenolanib, are also in clinical trials; In addition, B-cell leukemia 2 (BPL- 2) Inhibition, Hedgehog signaling pathway Inhibition, etc.
In addition, azacitidine can be used as a maintenance treatment for acute marrow leukemia. The side effects of oral azacitidine include vomiting, low white blood cell count, and infection, but they are usually controllable.
It was important to note that the above medications needed to be used under the guidance of a doctor.
<a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the suppressive drugs for acute marrow leukemia?Inhibition drugs for acute myeloid leukemia (AML) included chemotherapy drugs and targeted drugs.
The main types of chemotherapy drugs were mitoxantrone, daunorubin, cytarine, aclacinoxin, homoharringtonine, etc. The most common adverse reactions were digestive tract reactions (such as nausea, vomiting, etc.) and bone marrow suppression (such as leukemia, chemotherapy, etc.).
The targeted drugs mainly included gireitini (FLVT3), vineclakra, midostemine (FLVT3), avonib (IDH1), gemtubizab (CD33), ensidipine (IDH), gilitini, sorafenib, etc. The common side effects of targeted drugs included skin itching, rash, and digestive tract reactions. In addition, the targeted drugs approved by the Food and Drug Administration in 2017 - 2018 for the treatment of leukemia include the FMT3 receptor, midostaurin, the IDH2 receptor, enasidenib, and the IDH1 receptor, Ivosidenib. Among them, midostaurin can be used as first-line treatment and enasidenib can be used as salvage treatment.
All the above medicines must be used under the guidance of a doctor.
<a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Can you share some acute lymphoblastic leukemia success stories?One success story is of a young child named Lily. She was diagnosed with acute lymphoblastic leukemia. Through intense chemotherapy sessions over a period of two years, she fought bravely. Her family's support and the great medical team were crucial. Now, five years later, she is in complete remission, going to school like any other normal kid.
3 answers
2024-11-28 03:24
What are the latest drug treatments for acute marrow leukemia?The latest drug treatment plan for acute marrow leukemia was as follows:
1. ** Target Drug Treatment **
- For patients with FLVT3- ITD mutation, there are corresponding targeted drugs, such as gireitini, which has an suppressive effect on two common FLVT3 mutations found in about one-third of patients with acute marrow leukemia, FLVT3- ITD and FLVT3- TKD. It has been accepted in China for the treatment of FLVT3 mutation-positive patients.(FLVT3 mut +) for adult patients with relapsed or treatment-resistant acute myeloid leukemia, and the drug was approved for marketing in Japan and the United States in 2018 for the treatment of adult patients with relapsed or treatment-resistant FLVT3 mut acute myeloid leukemia.
- There were also targeted therapy drugs such as IDH2 inhibition drugs. These drugs benefited elderly patients a lot. Young patients could also reduce the side effects of chemotherapy drugs and improve their survival rate through such targeted therapy.
2. ** Chemistry **
- ** Induction treatment plan **: The classic "3+7" plan, which is to use an anthracycline-like drug for 3 days and cytarine for 7 days, can achieve a response rate of 60% - 80%.
- **CAG protocol **: It consists of aclarubin, cytarine, and colony stimulating factor. It is a low-dose long-term treatment protocol with the advantages of low toxicity and high safety.
- ** Demolation drugs **: For example, decitobin, azacitidine, etc. Azacitidine is a valuable alternative to chemotherapy for elderly patients with leukemia.
- ** New drugs for elderly patients **: such as clofarbine, Vosaroxin, CPX - 351, etc.
3. ** Hematopoetic stem cell transplant treatment **: Hematopoetic stem cell transplant is considered the most effective treatment for leukemia. However, despite the high rate of response, a considerable proportion of leukemia patients still relapse, and graft-versus-host disease is the main complication after hemopoetic stem cell transplant. For high-risk children, maintenance treatment after allogeneic stem cell transplantation was very important.
<a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Can you share more about acute myeloid leukemia success stories?In one case, a patient with acute myeloid leukemia participated in a clinical trial. The trial was for a new targeted therapy. This treatment was designed to attack the cancer cells while sparing the healthy cells as much as possible. The patient had great results from the trial. Their blood counts returned to normal, and they no longer showed any symptoms of the disease. They are now an example of how research and new treatments can bring hope to those with acute myeloid leukemia.